Elanco Animal Health Incorporated (ELAN) Earnings History
Net Loss10 years of earnings data (2016–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Elanco Animal Health Incorporated (ELAN) Earnings Overview
As of October 8, 2026, Elanco Animal Health Incorporated (ELAN) reported trailing twelve-month net income of -$199M, reflecting -169.1% year-over-year growth. The company earned $-0.39 per diluted share over the past four quarters, with a net profit margin of -4.9%.
Looking at the long-term picture, ELAN's historical earnings data spans multiple years. The company achieved its highest annual net income of $338M in fiscal 2024.
Elanco Animal Health Incorporated is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ZTS ($2.62B net income, 28.2% margin), PCRX ($15M net income, 1.0% margin), PAHC ($100M net income, 3.7% margin), ELAN has room to improve margins relative to the peer group. Compare ELAN vs ZTS →
ELAN Earnings vs Peers
Earnings metrics vs comparable public companies
ELAN Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$232M | -168.6% | $252M | $-0.47 | -4.9% | 5.3% |
| 2024 | $338M | +127.5% | $251M | $0.68 | 7.6% | 5.7% |
| 2023 | -$1.23B | -1478.2% | $326M | $-2.50 | -27.9% | 7.4% |
| 2022 | -$78M | +83.9% | $384M | $-0.15 | -1.8% | 8.7% |
| 2021 | -$483M | +13.8% | $304M | $-0.97 | -10.1% | 6.4% |
| 2020 | -$560M | -924.9% | -$77M | $-1.27 | -17.1% | -2.3% |
| 2019 | $68M | -21.5% | $370M | $0.18 | 2.2% | 12.0% |
| 2018 | $87M | +127.8% | $314M | $0.28 | 2.8% | 10.2% |
| 2017 | -$311M | -548.6% | $142M | $-0.87 | -10.8% | 4.9% |
| 2016 | -$48M | - | $283M | $-0.13 | -1.6% | 9.7% |
Download Data
Export ELAN earnings history in CSV or JSON format
Free sign-in required to download data
ELAN Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ELAN — Frequently Asked Questions
Quick answers to the most common questions about buying ELAN stock.
What is ELAN earnings per share (EPS)?
ELAN trailing twelve-month (TTM) diluted EPS is $-0.39, reflecting -169.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2016 to 2025 is available in the table on this page.
What is Elanco Animal Health Incorporated's net income?
Elanco Animal Health Incorporated (ELAN) trailing twelve-month net income is $-199M as of 2025. Earnings declined -169.1% year-over-year.
Is ELAN profitable?
ELAN is not currently profitable on a TTM basis, reporting a net loss of $-199M. Net margin is -4.9%. Investors should monitor for a return to profitability.
What is ELAN's earnings growth rate?
ELAN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2016 to 2025.
What are ELAN's profit margins?
Elanco Animal Health Incorporated net profit margin is -4.9%, operating margin is +5.3%, and gross margin is +43.5%. Below-average margins reflect competitive or cost pressures. Return on Equity is -3.7%.
Is ELAN growing earnings?
ELAN earnings are declining — EPS fell -169.1% year-over-year. TTM net income dropped to $-199M. This contrasts with the 5-year CAGR of N/A.
What was ELAN's best earnings year?
Elanco Animal Health Incorporated's highest annual net income on record is $338M, achieved in fiscal year 2024. Earnings history on this page spans 2016 to 2025 and includes all annual and quarterly figures.
What were ELAN's earnings last quarter?
ELAN's most recent reported quarter was Q2 2026. Net income was $54M with diluted EPS of $0.11. For a full breakdown of all quarters, see the quarterly earnings table on this page.